System enables nucleic acid purification from a wide range of viruses and is compliant with the IVD-D directive on in vitro diagnostic medical devices
The BioRobot MDx DSP system provides true walkaway purification of viral nucleic acids in clinical laboratories.
The CE-marked system (including instrument, software, service, and protocols for use with the QIAamp DSP 96 virus MDx kit) provides exact performance specifications, assuring highly reliable purification procedures for in vitro diagnostic purposes.
IVD-D compliance (with EU Directive 98/79/EC on in vitro diagnostic medical devices) makes validation and quality control fast and easy.
The generic nature of the system enables nucleic acid purification from a wide range of viruses and ensures that the system is compatible with a variety of upstream sample collection systems and downstream assay systems.
This streamlines integration into diagnostic workflows.
The BioRobot MDx DSP is a closed system that provides true walkaway automation, says Qiagen.
Ready-to-run protocols, secure user environments, and complete process documentation comply with regulatory requirements.
Bar code reading enables automated reagent and sample tracking.
Precision pipetting minimises the risk of cross-contamination, and an automated load check ensures high process reliability and error-free worktable setup.
The system requires a maximum of 2.5 hours to process 96 samples, in primary or secondary sample tubes, with no hands-on time.
Manual handling of potentially infectious samples is minimised, ensuring safety for the user and reliable processing of samples.
